ddrg/super_eurlex huggingface dataset:
Prior notification of a concentration

(Case M.9489 – Air Canada/Transat)

(Text with EEA relevance)

(2020/C 131/11)

1. On 15 April 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Air Canada (Canada), — Transat A.T. Inc. (‘Transat’, Canada). Air Canada acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Transat. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Air Canada: global airline that provides scheduled passenger air services in Canada, and internationally, including between Canada and Europe. Air Canada operates flights to Europe through its mainline fleet as well as through its subsidiary Air Canada Rouge, — for Transat: parent company of Air Transat which provides scheduled passenger air services in Canada and internationally, including between Canada and Europe. Transat is also active as an international holiday travel company that develops and markets holiday travel services in Canada, the Americas and Europe.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9489 – Air Canada/Transat Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.9794 – Renault/Ferrovial/Car Sharing Mobility Services)

(Text with EEA relevance)

(2020/C 167/03)

On 8 May 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9794. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.9801 – Allianz/OMERS Infrastructure/T&R JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 160/06)

1. On 5 May 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Allianz Capital Partners GmbH (‘ACP’, Germany), belonging to the group Allianz SE (Germany), — Borealis Turtle Investments BV (‘Borealis’, the Netherlands), wholly owned by OMERS Administration Corporation (‘OMERS’, Canada), — Autobahn Tank & Rast Gruppe GmbH & Co KG (‘T&R’, Germany). ACP and Borealis acquire within the meaning of Article 3(1)(b) and Article 3(4) of the Merger Regulation joint control of the whole of T&R. The concentration results from an amendment in the governance principles of T&R.

2. The business activities of the undertakings concerned are: — ACP is a wholly-owned subsidiary of Allianz SE, the ultimate parent company of the Allianz Group. The Allianz Group offers a comprehensive range of insurance and asset management products and services to both private and corporate customers in more than 70 countries. Pre-transaction, Allianz had sole control over T&R, — Borealis is the managing holding entity of the T&R investment on behalf of OMERS, the administrator of the Ontario Municipal Employees Retirement System Primary Pension Plan and the ultimate parent company of the OMERS group, one of Canada’s largest defined benefit pension plans. OMERS’ shareholding in T&R has not changed post-transaction, — T&R is a provider of food services, retail goods, hotel accommodation and fuel on German motorways.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9801 – Allianz/OMERS Infrastructure/T&R JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9780 — BNP Paribas/Bank of Baroda/JV)

(Text with EEA relevance)

(2020/C 180/03)

On 15 May 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9780. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9778 – TUI AG/RCCL/Hapag-Lloyd Cruises)

(Text with EEA relevance)

(2020/C 174/05)

1. On 15 May 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — TUI AG (‘TUI AG’, Germany), — Royal Caribbean Cruises Ltd (‘RCCL’, Liberia), — Hapag-Lloyd Kreuzfahrten GmbH (‘Hapag-Lloyd Cruises’, Germany). TUI AG and RCCL, through TUI Cruises GmbH (‘TUI Cruises’, Germany), acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Hapag-Loyd Cruises. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for TUI AG: the ultimate parent company of the TUI Group, an integrated leisure tourism group operating through its various subsidiaries hotels, cruise ships, airlines, aircraft, travel agencies, tour operators and online portals, — for RCCL: a global operator of oceanic cruises, — for TUI Cruises: a pre-existing joint venture jointly controlled by TUI AG and RCCL active in the provision of oceanic cruises, primarily to German-speaking customers, — for Hapag-Lloyd Cruises: the provision of oceanic cruises, primarily to German-speaking customers.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9778 – TUI AG/RCCL/Hapag-Lloyd Cruises Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Prior notification of a concentration

(Case M.9842 – Hitachi Chemical Company/Fiamm Energy Technology)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 196/05)

1. On 2 June 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Hitachi Chemical Company Ltd. (‘HCC’, Japan), controlled by Showa Denko K.K. (‘SDK’, Japan), — Fiamm Energy Technology S.p.A (‘FET’, Italy). HCC acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of FET. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for HCC: the production of functional materials such as electronics materials, inorganic materials, polymer science materials and printed wiring board materials and the production of advanced components and systems, such as automotive products, energy storage devices, electronics components and other diagnostic agents and instruments, — for FET: the production and distribution of lead acid starter batteries and stationary batteries. FET is currently jointly controlled by HCC and Elettra 1938 S.p.A. (‘Elettra’, Italy).

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9842 – Hitachi Chemical Company/Fiamm Energy Technology Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9850 – EQT Fund management/Schülke & Mayr) –

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 183/04)

1. On 25 May 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — EQT VIII (‘EQT’, Luxembourg), controlled by EQT Fund Management S.à r.l., — Schülke & Mayr GmbH (‘Schülke’, Germany). EQT acquires, within the meaning of Article 3(1)(b) of the Merger Regulation, sole control of the whole of Schülke. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — EQT. EQT is an investment fund that seeks to make investments primarily in Europe, with a focus on Northern Europe. — Schülke. Schülke is active in infection prevention and hygiene. Schülke develops, produces and distributes antiseptics for wound care, disinfectants, medical and cosmetic skin care products and preservatives.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9850 – EQT Fund management/Schülke & Mayr Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9587 – ENGIE/EDP Renováveis/EDPR Offshore España)

(Text with EEA relevance)

(2020/C 205/02)

On 25 February 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9587. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9328 – Platinum Equity Group/Multi-Color Corporation)

(Text with EEA relevance)

(2020/C 203/01)

On 11 June 2019, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32019M9328. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9803 – SAZKA Group/OPAP)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 217/09)

1. On 22 June 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — SAZKA Group a.s. (‘SAZKA Group’, Czech Republic), controlled by KKCG AG, and ultimately controlled by the VALEA Foundation, — OPAP S.A. (‘OPAP’, Greece). SAZKA Group acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of OPAP. The concentration is accomplished by way of contract or any other means and by way of of purchase of shares.

2. The business activities of the undertakings concerned are: — for SAZKA Group: active in the lottery, gaming, and betting sectors in the Czech Republic, Austria, and Italy, — for OPAP: active in the lottery, gaming and betting sectors in Greece and Cyprus.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9803 — SAZKA Group/OPAP Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: E-mail: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9782 – Experian/Bertelsman/Informa)

(Text with EEA relevance)

(2020/C 214/03)

On 16 June 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9782. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.9744 – Mastercard/Nets)

(Text with EEA relevance)

(2020/C 219/09)

1.

On 26 June 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 )

This notification concerns the following undertakings:

— Mastercard Incorporated (USA) (‘Mastercard’),

— Nets A/S (Denmark) (‘Nets’).

Mastercard acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of parts of Nets’ corporate services business (the ‘Target’).

The concentration is accomplished by way of purchase of shares.

The concentration has been referred to the Commission by the Danish Competition and Consumer Authority pursuant to Article 22 (3) of the Merger Regulation. The referral was subsequently joined by Austria, Finland, Norway, Sweden and the UK.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9711 – Alliance Healthcare Deutschland/Gehe Pharma Handel)

(Text with EEA relevance)

(2020/C 235/05)

1. On 10 July 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

— Alliance Healthcare Deutschland AG (Germany), controlled by Wallgreens Boots Alliance, Inc. (USA),

— Gehe Pharma Handel GmbH (Germany), controlled by McKesson Corporation (USA).

Alliance acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of Gehe.

The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — Alliance is a full-line pharmaceutical wholesaler, active mainly in Germany, — Gehe is a full-line pharmaceutical wholesaler, active mainly in Germany.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9711 – Alliance Healthcare Deutschland/Gehe Pharma Handel

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
6.

The Advisory Committee (10 Member States) agrees with the Commission’s definitions of the relevant geographic markets for fixed speed and variable speed light commercial compressors, namely that they are EEA-wide in geographic scope or, at least worldwide, with strong regional differentiations, where the EEA has to be considered as a region highly differentiated from others.